Related Articles:

Solution-phase and solid-phase synthesis of novel transition state inhibitors of coagulation enzymes incorporating a piperidinyl moiety

[Adang, Anton E. P.; Peters, Co A. M.; Gerritsma, Siene; De Zwart, Edwin; Veeneman, Gerrit Bioorganic and Medicinal Chemistry Letters, 1999 , vol. 9, # 9 p. 1227 - 1232]

Design, synthesis, and structure–activity relationships of potent GPIIb/IIIa antagonists: discovery of FK419

[Yamanaka, Toshio; Ohkubo, Mitsuru; Kuroda, Satoru; Nakamura, Hideko; Takahashi, Fumie; Aoki, Toshiaki; Mihara, Kayoko; Seki, Jiro; Kato, Masayuki Bioorganic and Medicinal Chemistry, 2005 , vol. 13, # 13 p. 4343 - 4352]

Design of a new class of orally active fibrinogen receptor antagonists

[Klein, Scott I.; Molino, Bruce F.; Czekaj, Mark; Gardner, Charles J.; Chu, Valeria; Brown, Karen; Sabatino, Ralph D.; Bostwick, Jeffrey S.; Kasiewski, Charles; Bentley, Ross; Windisch, Vincent; Perrone, Mark; Dunwiddie, Christopher T.; Leadley, Robert J. Journal of Medicinal Chemistry, 1998 , vol. 41, # 14 p. 2492 - 2502]

Design and synthesis of potent, orally active, inhibitors of carboxypeptidase U (TAFIa)

[Bioorganic and Medicinal Chemistry, , vol. 12, # 5 p. 1151 - 1175]

Design of a new class of orally active fibrinogen receptor antagonists

[Journal of Medicinal Chemistry, , vol. 41, # 14 p. 2492 - 2502]